Organovo Holdings, Inc. (0R02.L)

USD 0.26

(2.08%)

Total Debt Summary of Organovo Holdings, Inc.

  • Organovo Holdings, Inc.'s latest annual total debt in 2023 was 1.39 Million USD , down -22.77% from previous year.
  • Organovo Holdings, Inc.'s latest quarterly total debt in 2024 Q1 was 1.28 Million USD , down -7.82% from previous quarter.
  • Organovo Holdings, Inc. reported annual total debt of 1.8 Million USD in 2022, down -17.32% from previous year.
  • Organovo Holdings, Inc. reported annual total debt of 2.18 Million USD in 2021, down 0.0% from previous year.
  • Organovo Holdings, Inc. reported quarterly total debt of 1.39 Million USD for 2023 FY, down -22.77% from previous quarter.
  • Organovo Holdings, Inc. reported quarterly total debt of 1.6 Million USD for 2023 Q2, down -5.92% from previous quarter.

Annual Total Debt Chart of Organovo Holdings, Inc. (2023 - 2010)

Historical Annual Total Debt of Organovo Holdings, Inc. (2023 - 2010)

Year Total Debt Total Debt Growth
2023 1.39 Million USD -22.77%
2022 1.8 Million USD -17.32%
2021 2.18 Million USD 0.0%
2020 - USD 0.0%
2019 - USD 0.0%
2018 - USD 0.0%
2017 - USD 0.0%
2016 - USD 0.0%
2015 - USD -100.0%
2014 5000.00 USD -66.67%
2013 15 Thousand USD -44.44%
2012 27 Thousand USD 0.0%
2010 - USD 0.0%

Peer Total Debt Comparison of Organovo Holdings, Inc.

Name Total Debt Total Debt Difference
Xeris Biopharma Holdings, Inc. 229.19 Million USD 99.392%
Arrowhead Pharmaceuticals, Inc. 115.17 Million USD 98.79%
Codexis, Inc. 22.36 Million USD 93.767%
Viridian Therapeutics, Inc. 21.04 Million USD 93.377%